rs822396

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025): 0P and 4B. B1_Strong

The NM_004797.4(ADIPOQ):c.-8-3963G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene ADIPOQ is a tumor suppressor gene (CancerMine: 2 TSG, 6 oncogene citations). The gene ADIPOQ is a known oncogene (CancerMine: 2 TSG, 6 oncogene citations). The variant allele was found at a cumulative frequency of 0.813 (AC=123,746) in the gnomAD database across 152,116 control chromosomes, including 50,365 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.869. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.81 ( 50365 hom., cov: 31)

Consequence

ADIPOQ
NM_004797.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.976

Publications

106 publications found
Variant links:
Genes affected
ADIPOQ (HGNC:13633): (adiponectin, C1Q and collagen domain containing) This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010]
ADIPOQ Gene-Disease associations (from GenCC):
  • STAT3-related early-onset multisystem autoimmune disease
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004797.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 points.

B1
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.869 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_004797.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADIPOQ
NM_004797.4
MANE Select
c.-8-3963G>A
intron
N/ANP_004788.1Q15848
ADIPOQ
NM_001177800.2
c.-9+3481G>A
intron
N/ANP_001171271.1A8K660

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADIPOQ
ENST00000320741.7
TSL:1 MANE Select
c.-8-3963G>A
intron
N/AENSP00000320709.2Q15848
ADIPOQ
ENST00000444204.2
TSL:1
c.-9+3481G>A
intron
N/AENSP00000389814.2Q15848
ADIPOQ
ENST00000881747.1
c.-9+3481G>A
intron
N/AENSP00000551806.1

Frequencies

GnomAD3 genomes
AF:
0.813
AC:
123632
AN:
151998
Hom.:
50310
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.797
Gnomad AMI
AF:
0.769
Gnomad AMR
AF:
0.839
Gnomad ASJ
AF:
0.856
Gnomad EAS
AF:
0.890
Gnomad SAS
AF:
0.795
Gnomad FIN
AF:
0.819
Gnomad MID
AF:
0.842
Gnomad NFE
AF:
0.810
Gnomad OTH
AF:
0.831
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.813
AC:
123746
AN:
152116
Hom.:
50365
Cov.:
31
AF XY:
0.814
AC XY:
60545
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.797
AC:
33085
AN:
41490
American (AMR)
AF:
0.840
AC:
12839
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.856
AC:
2972
AN:
3472
East Asian (EAS)
AF:
0.891
AC:
4608
AN:
5172
South Asian (SAS)
AF:
0.795
AC:
3835
AN:
4824
European-Finnish (FIN)
AF:
0.819
AC:
8655
AN:
10566
Middle Eastern (MID)
AF:
0.864
AC:
254
AN:
294
European-Non Finnish (NFE)
AF:
0.810
AC:
55038
AN:
67982
Other (OTH)
AF:
0.833
AC:
1760
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1171
2341
3512
4682
5853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.816
Hom.:
216492
Bravo
AF:
0.817
Asia WGS
AF:
0.878
AC:
3053
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.950
AC:
116664
AN:
122794
Turkish Variome
AF:
0.810
AC:
1253
AN:
1546
Hom.:
506
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.876
AC:
7852
AN:
8960
Hom.:
3454
ABraOM SABE-WGS-1171
AF:
0.816
AC:
1912
AN:
2342
Hom.:
783

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.26
DANN
Benign
0.23
PhyloP100
-0.98
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.